RANGE IMPACT INC - RNGE STOCK NEWS

Range Impact (OTC: RNGE) has announced the sale of its cannabinoid drug development business, Graphium Biosciences, to Placer Biosciences. This strategic move allows Range Impact to focus on its environmental services business in Appalachia. The sale includes all of Graphium's assets, with Range Impact receiving warrants for 25% of Placer's common stock, a small cash amount, and 50% of proceeds from non-core equipment sales over the next year.

Graphium was developing early-stage cannabinoid-based therapeutics for gastrointestinal diseases without psychoactive side effects. The decision to divest came after a review of corporate strategies and market conditions. Range Impact's CEO, Michael Cavanaugh, expressed excitement about partnering with Placer Biosciences' leadership and their commitment to advancing the drug platform.

Range Impact, Inc. (OTC: RNGE) has announced its application to uplist from the OTC Pink Sheets to the OTCQB Venture Market. The OTCQB, operated by OTC Markets Group Inc., is designed for developing companies and is recognized by the SEC as an established public market for determining public market prices in securities resale registration.

CEO Michael Cavanaugh stated that uplisting to OTCQB could broaden the company's shareholder base and enhance visibility and transparency within the investment community. He also believes it could improve access to capital and create more efficient trading opportunities. If approved, Range Impact's common stock is expected to continue trading under the ticker symbol RNGE on the OTCQB.

Range Impact (OTC: RNGE) has announced the sale of non-core assets as part of its strategic plan to focus on reclaiming and repurposing Company-owned mine land in Appalachia. On August 22, 2024, the Company's subsidiary, Collins Building & Contracting, sold a mechanics shop, stone quarry, and related assets to entities controlled by Roger L. Collins, Jr. In exchange, $2,940,836 of debt was cancelled and discharged.

This decision comes after a review of the Company's abandoned mine land (AML) reclamation business in West Virginia, which was deemed administratively and operationally challenging. CEO Michael Cavanaugh stated that exiting this line of business allows Range Impact to concentrate on reclaiming and repurposing its own mine land, which is believed to offer greater long-term value creation opportunities for shareholders.

Range Impact (OTC: RNGE) reported its Q2 2024 financial results, showing a decline in revenue and negative Adjusted EBITDA. Key highlights include:

- Consolidated revenue of $2,349,738 in Q2 2024, down from $3,998,267 in Q2 2023
- Consolidated Adjusted EBITDA of ($312,994) in Q2 2024, compared to $479,405 in Q2 2023
- Net loss of $1,225,681 in Q2 2024, versus a net income of $36,762 in Q2 2023

The decline was primarily attributed to a mining contractor's performance failure and misalignment between revenues and costs in the Range Reclaim segment. Management plans to review business segments and take steps to reposition the company for future growth and profitability.

Range Impact (OTC: RNGE) reported first-quarter results for 2024, showing a consolidated revenue increase to $3,909,893, up $895,006 from 1Q 2023. However, the company's consolidated Adjusted EBITDA decreased to $67,034, down from $170,961 in 1Q 2023.

The Range Reclaim segment saw a revenue decline by $1,482,504 to $1,505,983, while Range Minerals, a newly separate segment, reported $1,982,115 in revenue. Range Security also showed strong growth, with revenue up to $421,795 from $26,400 in 1Q 2023.

Operating expenses increased to $1,075,541, contributing to a net loss of $751,149, compared to a net loss of $226,860 in 1Q 2023. Cash flow from operations turned negative at $(1,113,045). The company emphasizes its commitment to reclaiming and repurposing mine sites for sustainable economic activity in Appalachia.

Range Impact, Inc. (OTC: RNGE) announces the transition of two executives to Graphium Biosciences Subsidiary as part of a proposed divestiture, while promoting a new Chief Financial Officer. The company, formerly focused on biotech research, now includes impact investing in Appalachia. The transition aligns with a capital raise for Graphium's divestiture, ensuring leadership continuity for drug development plans.

Range Impact, Inc. (RNGE) reports strong financial performance for Q4 2023 and FY 2023 with significant revenue growth. The company's revenue increased to $19.3 million in FY 2023 from $4.8 million in FY 2022, driven by successful acquisitions and strategic initiatives. Operating income improved, reaching $1.75 million in FY 2023 compared to a loss in FY 2022. Despite a net loss in Q4 2023, the full year saw a substantial increase in net income. Adjusted EBITDA also showed positive growth. Range Impact's CEO, Michael Cavanaugh, highlighted the company's focus on impact investing in Appalachia and outlined future revenue projections.

Range Impact, Inc. (RNGE) has appointed former U.S. Congressman Zack Space and former Ohio State Senator Jay Hottinger, President and Executive Vice President, respectively, of Sunday Creek Horizons LLC, as Strategic Advisors. The company engaged Sunday Creek Horizons in May 2023 to focus on improving the health, wealth, and quality of life of citizens living in the rural communities of Appalachia. Congressman Space and Senator Hottinger will help propel the growth and expansion of Range Impact's ambitious vision throughout Appalachia.

Range Impact, Inc. (OTC: RNGE) announced the closing of a $1,700,000 capital raise led by Intelligent Fanatics Capital Management, Carlson Ridge Capital, and Dickinson Group, among others. The investors acquired a total of 11,333,336 shares of Range Impact’s common stock at a price of $0.15 per share. Michael Cavanaugh, Range Impact’s CEO, expressed excitement about the strategic capital and valuable insights brought by the new shareholders.